Related Experiment Video

Updated: Jun 24, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Patient selection for left-ventricular assist devices

Katherine Lietz1, Leslie W Miller

  • 1Cardiovascular Divisions, Columbia-University Medical Center, New York, New York, USA. KL2384@columbia.edu

Current Opinion in Cardiology
|March 26, 2009
PubMed

Insights

Selecting the right patients is crucial for successful left-ventricular assist device (LVAD) implantation. This review outlines a systematic approach to evaluating end-stage heart failure patients for LVAD candidacy.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Left-ventricular assist device (LVAD) implantation is a critical intervention for end-stage heart failure.
  • Patient selection is a key determinant of successful LVAD outcomes.
  • Advances in LVAD technology necessitate refined candidate evaluation strategies.

Purpose of the Study:

  • To present a comprehensive, step-by-step approach for evaluating patients with end-stage heart failure for LVAD implantation.
  • To summarize current guidelines and best practices for LVAD candidate selection.
  • To discuss the optimal timing and risk stratification for LVAD procedures.

Main Methods:

  • Review of recently published guidelines on mechanical circulatory support.
  • Analysis of current understanding regarding the optimal timing of LVAD placement.
  • Evaluation of preoperative screening scales for operative risk assessment.

Main Results:

  • Provides a structured framework for LVAD candidate evaluation.
  • Summarizes recent guidelines for long-term mechanical circulatory support.
  • Discusses the utility of preoperative screening scales for risk stratification.

Conclusions:

  • Refined patient selection is paramount for optimizing LVAD outcomes.
  • Continued research is needed to define clinical determinants of successful LVAD implantation.
  • Technological advancements in LVADs require ongoing efforts to improve candidate selection criteria.
Abstract

More Related Videos

Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...